145 related articles for article (PubMed ID: 16028175)
1. Tenofovir and changes in renal function.
Gupta SK
Clin Infect Dis; 2005 Aug; 41(4):570-1; author reply 571. PubMed ID: 16028175
[No Abstract] [Full Text] [Related]
2. Improvement in chronic renal impairment following the discontinuation of tenofovir in two HIV-infected patients.
Gracey D; Post J; MacLeod C; McKenzie P
Nephrology (Carlton); 2011 May; 16(4):453-5. PubMed ID: 21518120
[No Abstract] [Full Text] [Related]
3. Editorial comment: tenofovir-related nephrotoxicity--who's at risk?
Gupta Samir K
AIDS Read; 2007 Feb; 17(2):102-3. PubMed ID: 17323509
[No Abstract] [Full Text] [Related]
4. Renal safety of tenofovir disoproxil fumarate.
Sax PE; Gallant JE; Klotman PE
AIDS Read; 2007 Feb; 17(2):90-2, 99-104, C3. PubMed ID: 17323508
[TBL] [Abstract][Full Text] [Related]
5. Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment.
Gallant JE; Parish MA; Keruly JC; Moore RD
Clin Infect Dis; 2005 Apr; 40(8):1194-8. PubMed ID: 15791522
[TBL] [Abstract][Full Text] [Related]
6. Tenofovir-induced nephrotoxicity: myths and facts.
Gupta A; Bugeja A; Kirpalani D
Saudi J Kidney Dis Transpl; 2012 Jan; 23(1):148-9. PubMed ID: 22237241
[No Abstract] [Full Text] [Related]
7. Tenofovir and changes in renal function.
Flandre P
AIDS; 2010 Feb; 24(4):619-20. PubMed ID: 20195075
[No Abstract] [Full Text] [Related]
8. The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy.
Parsonage MJ; Wilkins EG; Snowden N; Issa BG; Savage MW
HIV Med; 2005 Sep; 6(5):341-6. PubMed ID: 16156882
[TBL] [Abstract][Full Text] [Related]
9. Tenofovir-induced acute renal failure in an HIV patient with normal renal function.
Krummel T; Parvez-Braun L; Frantzen L; Lalanne H; Marcellin L; Hannedouche T; Moulin B
Nephrol Dial Transplant; 2005 Feb; 20(2):473-4. PubMed ID: 15673708
[No Abstract] [Full Text] [Related]
10. Effect of tenofovir on renal glomerular and tubular function.
Fux CA; Christen A; Zgraggen S; Mohaupt MG; Furrer H
AIDS; 2007 Jul; 21(11):1483-5. PubMed ID: 17589197
[TBL] [Abstract][Full Text] [Related]
11. Editorial comment: tenofovir nephrotoxicity--the disconnect between clinical trials and real-world practice.
Atta MG; Fine DM
AIDS Read; 2009 Mar; 19(3):118-9. PubMed ID: 19334329
[No Abstract] [Full Text] [Related]
12. Editorial comment: mixing tenofovir with other nephrotoxins--how safe is this?
Gupta SK
AIDS Read; 2009; 19(6):246. PubMed ID: 19642244
[No Abstract] [Full Text] [Related]
13. Tenofovir nephrotoxicity: focusing research questions and putting them into clinical context.
Szczech LA
J Infect Dis; 2008 Jan; 197(1):7-9. PubMed ID: 18171278
[No Abstract] [Full Text] [Related]
14. Renal function in antiretroviral-experienced patients treated with tenofovir disoproxil fumarate associated with atazanavir/ritonavir.
Gérard L; Chazallon C; Taburet AM; Girard PM; Aboulker JP; Piketty C
Antivir Ther; 2007; 12(1):31-9. PubMed ID: 17503745
[TBL] [Abstract][Full Text] [Related]
15. Renal toxicity associated with tenofovir use.
Rodriguez-Nóvoa S; Alvarez E; Labarga P; Soriano V
Expert Opin Drug Saf; 2010 Jul; 9(4):545-59. PubMed ID: 20384533
[TBL] [Abstract][Full Text] [Related]
16. Acute renal failure in patients with AIDS on tenofovir while receiving prolonged vancomycin course for osteomyelitis.
Psevdos G; Gonzalez E; Sharp V
AIDS Read; 2009; 19(6):245-8. PubMed ID: 19642243
[TBL] [Abstract][Full Text] [Related]
17. Nephrolithiasis and hydronephrosis in an HIV-infected man receiving tenofovir.
Cicconi P; Bongiovanni M; Melzi S; Tordato F; d'Arminio Monforte A; Bini T
Int J Antimicrob Agents; 2004 Sep; 24(3):284-5. PubMed ID: 15325433
[TBL] [Abstract][Full Text] [Related]
18. Acute renal failure in HIV patients with liver cirrhosis receiving tenofovir: a report of two cases.
Blaas S; Schneidewind A; Glück T; Salzberger B
AIDS; 2006 Aug; 20(13):1786-7. PubMed ID: 16931948
[No Abstract] [Full Text] [Related]
19. Proximal tubular dysfunction associated with tenofovir and didanosine causing Fanconi syndrome and diabetes insipidus: a report of 3 cases.
Irizarry-Alvarado JM; Dwyer JP; Brumble LM; Alvarez S; Mendez JC
AIDS Read; 2009 Mar; 19(3):114-21. PubMed ID: 19334328
[TBL] [Abstract][Full Text] [Related]
20. Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations.
Rodríguez-Nóvoa S; Labarga P; D'avolio A; Barreiro P; Albalate M; Vispo E; Solera C; Siccardi M; Bonora S; Di Perri G; Soriano V
AIDS; 2010 Apr; 24(7):1064-6. PubMed ID: 20299966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
